Johnson & Johnson considers itself “uniquely positioned to lead the next wave of healthcare innovation.” Ahead of a meeting with the investment community today, the company outlined its views on where it stands in the medtech and pharmaceutical markets. New Brunswick, New Jersey-based Johnson & Johnson set long-term financial targets, including at least 3% sales […]
News Well
GE HealthCare, AirStrip partner on patient monitoring, cardiac data visualization
GE HealthCare announced today that it entered into a joint commercialization agreement with AirStrip to distribute patient monitoring technology. AirStrip, a member of the Nantworks group of AI-driven companies, develops cardiology and patient monitoring solutions. These technologies offer data visualization technology through a proprietary, native mobile application. Clinicians can see clinical data on mobile devices […]
BD recalls more Alaris pumps due to compatibility issues with Cardinal Health syringes
The FDA determined that another recall of BD Alaris infusion pumps is Class I, the most serious kind. In the latest Alaris recall, the company cites compatibility issues with Cardinal Health Monoject syringes. The issue mainly relates to changes made to the products by Cardinal Health. It affects more than 1 million total devices. BD’s […]
Asensus makes another Senhance surgical robot sale
Asensus Surgical (NYSE:ASXC) announced today that it made another sale of its Senhance surgical robot system. Research Triangle Park, North Carolina-based Asensus made the sale to its distribution partner. The latest sale of Senhance means the system will be placed in a hospital in the Commonwealth of Independent States region, which includes Russia and many […]
Intuitive Ventures brings in $150M to support minimally invasive care startups
Intuitive Ventures announced today that it closed a $150 million funding round to support early-stage minimally invasive care companies. Surgical robotics pioneer Intuitive Surgical launched Intuitive Ventures with $100 million in funding more than three years ago. The early-stage fund earmarked its latest round of funding, labeled “Fund II,” for three areas of investment focus. […]
Are investors overreacting on AtriCure after Medtronic’s Penditure launch?
BTIG analysts say a small survey of surgeons may indicate an oversell of AtriCure stock following Medtronic’s launch of a competing device. Medtronic this week launched the Penditure left atrial appendage (LAA) exclusion device, adding another system to a competitive space. AtriCure, Abbott and Boston Scientific all offer LAA devices, while Johnson & Johnson MedTech […]
Nevro acquires joint fusion device maker Vyrsa, closes credit facility and refinancing
Nevro (NYSE:NVRO) announced that it acquired Vyrsa Technologies, a company developing a minimally invasive joint pain treatment. Vyrsa has a portfolio of sacroiliac (SI) joint pain devices for use in SI joint fusion procedures. Established in 2021, the company manufactures and supports a complete portfolio of FDA-cleared devices. Dr. David Caraway, Nevro chief medical officer, […]
Elon Musk denies Neuralink monkey death claims, U.S. lawmakers want SEC probe
Elon Musk has responded to claims of grisly deaths suffered by test monkeys as a result of his Neuralink venture’s brain implant. Musk’s Neuralink brain-computer interface (BCI) company has been in the news for positive reasons over the past year or so. The company won regulatory for a first-in-human implant in May, and in September it opened […]
Johnson & Johnson MedTech enters LAA device space with acquisition of Laminar
Johnson & Johnson MedTech announced today that it completed the acquisition of left atrial appendage (LAA) device maker Laminar. The deal, which includes a $400 million upfront payment, adds Johnson & Johnson MedTech to the crowded LAA device space. Established devices like Abbott’s Amplatzer Amulet and Boston Scientific’s Watchman already exist within the market. Medtronic […]
Bright Uro raises $23M Series A to support urodynamics system
Bright Uro announced today that it closed $23 million in a Series A funding round to support its Glean urodynamics system. Irvine, California–based Bright Uro plans to use the funding to help garner FDA 510(k) clearance for Glean. It set its sights on a U.S. launch for the product in 2024. Glean, a comprehensive system, […]
ReValve reports successful first-in-human implant of next-gen TMVR
ReValve Solutions announced today that doctors successfully treated the first patient with its next-generation replacement heart valve. Cardiologists at the Punta Pacifica Hospital, Panama City, Panama, performed the procedure. An 81-year-old male with a history of heart failure received the Palmetto transcatheter mitral valve replacement (TMVR). The patient also had a series of failed surgical […]
